Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Chlorpheniramine + phenylephrine is an oral combination drug used to relieve symptoms associated with the common cold, seasonal allergies, hay fever, or sinus inflammation. It combines two active ingredients: **Chlorpheniramine**, an antihistamine that blocks histamine H1 receptors to reduce symptoms like sneezing, itching, watery eyes, and runny nose; **Phenylephrine**, a sympathomimetic decongestant that acts as an alpha‑adrenergic receptor agonist to constrict blood vessels in the nasal passages, thereby reducing nasal congestion. This combination provides short-term relief of multiple upper respiratory symptoms such as runny or stuffy nose, sneezing, itchy/watery eyes or throat, sinus congestion/pressure. It is available over-the-counter in various formulations including tablets and liquids[1][2][4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on chlorpheniramine + phenylephrine.